Deep Blue is developing a novel hernia mesh to address the unacceptably high rate of hernia occurrence and recurrence.
Deep Blue Medical Advances has raised $5.6M in total funding. The most recent round was Series A. The last funding was announced in April 2026.
Deep Blue Medical Advances's investors include TCA Venture Group, Sacramento Angels, Triangle Angel Partners, SeedFolio, baymed venture partners.
Deep Blue Medical Advances is headquartered in Durham, United States.
Deep Blue is developing a novel hernia mesh to address the unacceptably high rate of hernia occurrence and recurrence.
Deep Blue Medical Advances is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Deep Blue Medical Advances — Funding & Investors." VCBacked, April 21, 2026, https://www.vcbacked.co/company/deep-blue-medical-advances. Accessed September 15, 2026.
VCBacked. (2026). Deep Blue Medical Advances — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/deep-blue-medical-advances
{{cite web |title=Deep Blue Medical Advances — Funding & Investors |url=https://www.vcbacked.co/company/deep-blue-medical-advances |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated